Calliditas Therapeutics AB (CALT) Financials
CALT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 147.6 million | 115.3 million |
2023-06-30 | 157.5 million | 111.0 million |
2023-03-31 | 188.4 million | 114.5 million |
CALT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | -5.7 million | ? |
2023-06-30 | -15.0 million | ? |
2023-03-31 | 22.0 million | 3.5 million |
CALT Net Income
No data available :(
CALT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-09-30 | 72.1 million | - | 2.7 million |
2023-06-30 | 79.8 million | - | 1.9 million |
2023-03-31 | 120.5 million | - | - |
CALT Shares Outstanding
CALT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-09-30 | - | 16.5 million | 8.1 million | 15.6 million |
2023-06-30 | - | 8.2 million | 7.1 million | 17.6 million |
2023-03-31 | 242384 | 9.9 million | 7.8 million | 18.5 million |
CALT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | 27.0 million | 1.4 million |
2023-06-30 | 24.8 million | 1.3 million |
2023-03-31 | 41.4 million | 760251 |
CALT
Price: $20
52 week price:
Earnings Per Share: -1.64 USD
P/E Ratio: -13.18
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 12700
Market Capitalization: 613.2 million